ArchiMed's Bomi bolts on Florence Shipping

With this acquisition, Bomi plans to strengthen its portfolio of logistic solutions dedicated to global forwarding and clinical trials management through a newly established business unit, Bomi Health Forwarding. The new division will be led by Florence Shipping CEO Guido Dapporto.

This is the third add-on inked by Bomi, following its acquisition of Logifarma, an Italian logistics business for the pharmaceutical industry; and the bolt-on of Ecuador-based Integrated Logistics Services (ILS).

Established in 1985 and based in Vaprio d'Adda, near Milan, Bomi specialises in transport, warehousing and supply-chain management for healthcare companies ranging from pharmaceutical and medical equipment manufacturers to hospitals, testing laboratories and outpatient services. The business operates in 20 countries across Europe, the Americas and Asia, and generates EBITDA of around €12m from revenues of €125m.

ArchiMed acquired Bomi in a €70m take-private in May 2019, de-listing the company from the Milan stock exchange. The GP invested in the business via its mid-market fund Med Platform I, which was launched in 2018 with a target of €800m and held a final close on €1bn in August 2020.

Company
Established in 1988, Florence Shipping specialises in freight forwarding and logistics, primarily for the pharma industry.

The company provides thermal shock sensitive and dangerous materials shipments across more than 60 countries around the world.

People
Bomi – Marco Ruini (CEO).
Florence Shipping – Guido Dapporto (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Portfolio management
• Southern Europe
• Industrials
• Archimed
• Italy
• Build-up
• Buy-and-build